Vireo Health Launches Lower-THC 'LiteBud' Brand – New Cannabis Ventures

LiteBud Products Designed for Cannabis Consumers Seeking a More Consistent, Controlled, and Mild Experience

MINNEAPOLIS, Jan. 6, 2020 /PRNewswire/ — Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO,OTCQX: VREOF), a leading physician-led, science-focused multi-state cannabis company, today announced the launch of LiteBud, a patent-pending line of consistently formulated, lower-Tetrahydrocannabinol (THC) cannabis products that are designed to meet the needs of cannabis consumers seeking a more consistent, controlled and mild experience.

Research studies conducted at the University of Mississippi found that the THC potency of cannabis plant material has more than quadrupled over the past generation. In 1995, the average THC potency was approximately 4%, increasing to 8.9% in 2008, and then again to 17.1% in 2017. Today, most flower available in medical and adult-use markets is cultivated to maximize potency and sophisticated techniques often yield THC levels that exceed 25%, in contrast to LiteBud products which contain lower THC levels, ranging from 4 to 10%.

Vireo is committed to creating innovative products that reflect the needs of all cannabis consumers. LiteBud offers patients a lower-THC product line with carefully controlled cannabinoid levels to help prevent the unpleasant side effects many experience with high-THC products. In a sense, this is your father’s cannabis since its cannabinoid levels are more reminiscent of the type of flower that was widely used a generation or two ago.

Chief Executive Officer Kyle Kingsley, M.D.

The first LiteBud product offering is a pre-roll made from slow-cured dry flower using a proprietary process to ensure lower levels of THC. LiteBud pre-rolls are the first product of its kind sold in Maryland’s growing medical cannabis market.

Our LiteBud brand strategy is informed, in part, by the success of the light beer market. As the U.S. cannabis market matures and serves a

Read More Here...

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top